nafenopin has been researched along with phenobarbital in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (44.83) | 18.7374 |
| 1990's | 13 (44.83) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bjondahl, K | 1 |
| Keulemans, K; Meijer, DK; Vonk, RJ; Weitering, JG | 1 |
| Dirven, HA; Jongeneelen, FJ; Noordhoek, J; Peters, JG; van den Broek, PH | 1 |
| Bursch, W; Gerbracht, U; Kraus, P; Putz, B; Reinacher, M; Schulte-Hermann, R; Timmermann-Trosiener, I | 1 |
| Erber, E; Parzefall, W; Schulte-Hermann, R; Sedivy, R | 1 |
| Gerbracht, U; Huber, W; Kraupp-Grasl, B; Putz, B; Schulte-Hermann, R | 1 |
| Huber, W; Kraupp-Grasl, B; Schulte-Hermann, R; Taper, H | 1 |
| Préat, V; Roberfroid, M | 1 |
| Bursch, W; Gerbracht, U; Kraupp-Grasl, B; Schulte-Hermann, R; Timmermann-Trosiener, I | 1 |
| Furukawa, K; Furukawa, NT; Furuya, K; Numoto, S; Williams, GM | 1 |
| de Gerlache, J; Lans, M; Préat, V; Roberfroid, M; Taper, H | 2 |
| Bentley, P; Bieri, F; Muakkassah-Kelly, SF; Stäubli, W; Waechter, F | 1 |
| Furuya, K; Levine, WG; Mori, H; Numoto, S; Williams, GM | 1 |
| Dalton, C; Hope, HR; Hope, WC; Sheppard, H | 1 |
| Bentley, P; Bieri, F; Fröhlich, E; Stäubli, W; Waechter, F | 1 |
| Ohde, G; Schulte-Hermann, R; Schuppler, J; Timmermann-Trosiener, I | 1 |
| Andreis, PG; Armato, U; Romano, F | 1 |
| Arch, JR; Cawthorne, MA; Green, A | 1 |
| Oberhammer, FA; Qin, HM | 1 |
| Delzenne, NM; Roberfroid, M; Taper, HS | 1 |
| Grasl-Kraupp, B; Huber, W; Schulte-Hermann, R; Waldhör, T | 1 |
| James, NH; Roberts, RA | 1 |
| Mori, H; Okumura, A; Tanaka, T | 1 |
| Garberg, P; Grasl-Kraupp, B; Högberg, J; Thullberg, M | 1 |
| Cattley, RC; Christensen, JG; Goldsworthy, TL; Gonzales, AJ | 1 |
| Gonzalez, FJ; Hasmall, SC; James, NH; Macdonald, N; Peters, JM; Roberts, RA | 1 |
| Chabicovsky, M; Grasl-Kraupp, B; Peter, B; Rossmanith, W; Schausberger, E; Schulte-Hermann, R | 1 |
| Bursch, W; Hufnagl, K; Schulte-Hermann, R; Wastl, U | 1 |
29 other study(ies) available for nafenopin and phenobarbital
| Article | Year |
|---|---|
A study on cerium-induced liver injury in rats after pretreatment with spironolactone, phenobarbital, pregnenolone-16 alpha-carbonitrile and nafenopin.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cerium; Chemical and Drug Induced Liver Injury; Female; Nafenopin; Phenobarbital; Pregnenolone Carbonitrile; Propionates; Rats; Spironolactone; Time Factors; Triglycerides | 1978 |
Hepatic uptake and biliary excretion of dibromosulphthalein. Albumin dependence, influence of phenobarbital and nafenopin pretreatment and the role of y and z protein.
Topics: Animals; Bile; Carrier Proteins; Cytosol; Glutathione Transferase; In Vitro Techniques; Kinetics; Liver; Male; Models, Biological; Nafenopin; Perfusion; Phenobarbital; Propionates; Protein Binding; Rats; Serum Albumin; Serum Albumin, Bovine; Sulfobromophthalein | 1977 |
Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds.
Topics: Adipates; Animals; Aroclors; Body Weight; Chlorodiphenyl (54% Chlorine); Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Enzyme Induction; Male; Methylcholanthrene; Microbodies; Microsomes, Liver; Mixed Function Oxygenases; Nafenopin; Organ Size; Oxidoreductases; Phenobarbital; Rats; Rats, Inbred Strains | 1992 |
Effects of hypolipidemic drugs nafenopin and clofibrate on phenotypic expression and cell death (apoptosis) in altered foci of rat liver.
Topics: Animals; Body Weight; Carcinogens; Cell Survival; Clofibrate; Cyproterone; Cyproterone Acetate; Female; Glutathione Transferase; Hexachlorocyclohexane; Liver; Liver Neoplasms, Experimental; Nafenopin; Nitrosamines; Organ Size; Phenobarbital; Phenotype; Precancerous Conditions; Propionates; Rats; Rats, Inbred Strains | 1990 |
Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters.
Topics: Adult; Aged; Autoradiography; Carcinogens; Cyproterone; Cyproterone Acetate; DNA; Dose-Response Relationship, Drug; Epidermal Growth Factor; Female; Gene Expression Regulation; Hexachlorocyclohexane; Humans; In Vitro Techniques; Liver; Male; Middle Aged; Nafenopin; Phenobarbital; Recombinant Proteins; Rifampin | 1991 |
Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver.
Topics: Aflatoxin B1; Aflatoxins; Animals; Body Weight; Carcinoma; Female; gamma-Glutamyltransferase; Liver; Liver Neoplasms, Experimental; Male; Nafenopin; Phenobarbital; Propionates; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
Topics: Aging; Animals; Liver; Liver Neoplasms, Experimental; Male; Microbodies; Nafenopin; Phenobarbital; Precancerous Conditions; Rats; Rats, Inbred Strains; Reference Values | 1991 |
Modulation of neoplastic development: concepts and examples.
Topics: Animals; Carcinogens; Cell Transformation, Neoplastic; Diet; Enzyme Induction; Hepatectomy; Liver Neoplasms, Experimental; Mice; Models, Biological; Nafenopin; Neoplasms, Experimental; Phenobarbital; Portacaval Shunt, Surgical; Rats; Xenobiotics | 1990 |
Effects of non-genotoxic hepatocarcinogens phenobarbital and nafenopin on phenotype and growth of different populations of altered foci in rat liver.
Topics: Aging; Animals; Carcinogenicity Tests; Carcinogens; Cell Survival; Female; gamma-Glutamyltransferase; Liver; Liver Neoplasms, Experimental; Microbodies; Nafenopin; Phenobarbital; Phenotype; Propionates; Rats | 1989 |
Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
Topics: Animals; Body Weight; Catalase; gamma-Glutamyltransferase; Glutathione Peroxidase; Glutathione Transferase; In Vitro Techniques; Kinetics; Liver; Liver Neoplasms; Male; Microbodies; Nafenopin; Organ Size; Phenobarbital; Propionates; Rats; Rats, Inbred F344 | 1985 |
Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis.
Topics: Animals; Butylated Hydroxytoluene; Cocarcinogenesis; DDT; gamma-Glutamyltransferase; Liver Neoplasms, Experimental; Nafenopin; Phenobarbital; Precancerous Conditions; Rats | 1986 |
Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
Topics: 2-Acetylaminofluorene; Animals; Carcinogens; Diethylnitrosamine; gamma-Glutamyltransferase; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Nafenopin; Phenobarbital; Propionates; Rats; Rats, Inbred Strains | 1986 |
Long-term maintenance of hepatocytes in primary culture in the presence of DMSO: further characterization and effect of nafenopin, a peroxisome proliferator.
Topics: Animals; Cells, Cultured; Culture Media; Cytochrome P-450 Enzyme System; Dimethyl Sulfoxide; DNA; Endoplasmic Reticulum; Enzyme Induction; Liver; Male; Methylcholanthrene; Microbodies; Microscopy, Electron; Nafenopin; Oxidoreductases; Palmitoyl Coenzyme A; Phenobarbital; Propionates; Rats; Rats, Inbred Strains | 1987 |
Absence of a promoting or sequential syncarcinogenic effect in rat liver by the carcinogenic hypolipidemic drug nafenopin given after N-2-fluorenylacetamide.
Topics: 2-Acetylaminofluorene; Administration, Oral; Animals; Body Weight; Carcinogens; Drug Synergism; Liver Neoplasms; Male; Nafenopin; Neoplasms, Experimental; Phenobarbital; Propionates; Rats; Rats, Inbred F344 | 1985 |
Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs.
Topics: Animals; Cholesterol; Clofibrate; Dactinomycin; DNA; Dose-Response Relationship, Drug; Glycolates; Hepatomegaly; Hypolipidemic Agents; In Vitro Techniques; Liver; Male; Microsomes, Liver; Mitochondria, Liver; Nafenopin; Oxidoreductases, N-Demethylating; Phenobarbital; Phenyl Ethers; Phenytoin; Phospholipids; Piperazines; Piperidines; Propionates; Proteins; Rats; RNA; Spectrophotometry, Ultraviolet; Triglycerides | 1974 |
Inhibitory effect of nafenopin upon the development of diethylnitrosamine-induced enzyme-altered foci within the rat liver.
Topics: Animals; Cocarcinogenesis; Diethylnitrosamine; Epoxide Hydrolases; gamma-Glutamyltransferase; Liver; Nafenopin; Nitrosamines; Organ Size; Phenobarbital; Propionates; Rats | 1984 |
Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin.
Topics: Animals; Autoradiography; Cell Division; Cocarcinogenesis; DNA; Female; gamma-Glutamyltransferase; Hexachlorocyclohexane; Liver Neoplasms; Mitogens; Nafenopin; Neoplasms, Experimental; Phenobarbital; Precancerous Conditions; Rats | 1981 |
The tumor promoters TPA, phenobarbital, and nafenopin and the prostaglandins of A, E, and F series overcome the G1/S block imposed by extracellular calcium deprivation on neonatal rat hepatocytes.
Topics: Animals; Calcium; Carcinogens; Cell Cycle; Cells, Cultured; DNA Replication; Female; Hormones; Imidazoles; Indomethacin; Liver; Male; Nafenopin; Phenobarbital; Prostaglandins; Rats; Rats, Inbred Strains; Tetradecanoylphorbol Acetate | 1984 |
Effects of nafenopin, diphenylhydantoin, phenobarbitone and some acetylenes on body composition: is there a relationship between decreased carcass lipid and increased liver size and induction of drug metabolizing enzymes?
Topics: Acetylene; Alkynes; Animals; Body Composition; Chemical Phenomena; Chemistry; Eating; Lipid Metabolism; Liver; Mice; Mice, Obese; Nafenopin; Organ Size; Oxygen Consumption; Phenobarbital; Phenytoin; Propionates | 1980 |
Effect of three tumour promoters on the stability of hepatocyte cultures and apoptosis after transforming growth factor-beta 1.
Topics: Apoptosis; Carcinogens; Cell Differentiation; Cells, Cultured; Cyproterone Acetate; Epidermal Growth Factor; In Vitro Techniques; Liver; Nafenopin; Phenobarbital; Proliferating Cell Nuclear Antigen; Time Factors; Transforming Growth Factor beta | 1995 |
Modifications of liver bile acids pool during modulation of rat hepatocarcinogenesis by phenobarbital and nafenopin.
Topics: Animals; Bile Acids and Salts; Liver; Liver Neoplasms, Experimental; Male; Nafenopin; Phenobarbital; Rats; Rats, Wistar | 1994 |
Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital.
Topics: Adenoma; Aflatoxin B1; Animals; Carcinogens; Female; Glutathione Transferase; Isoenzymes; Liver; Liver Neoplasms, Experimental; Macromolecular Substances; Male; Microbodies; Nafenopin; Phenobarbital; Rats; Rats, Wistar | 1993 |
Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
Topics: Animals; Apoptosis; Blood; Clofenapate; Cricetinae; Culture Media; DNA Damage; DNA Replication; Dogs; Guinea Pigs; Homeostasis; Male; Mice; Microbodies; Nafenopin; Phenobarbital; Pyrimidines; Rats; Species Specificity; Transforming Growth Factors | 1996 |
Simultaneous measurement of unscheduled and replicating DNA synthesis by means of a new cell culture insert DNA retention method: rapid induction of replicating DNA synthesis in response to genotoxic carcinogens.
Topics: 2-Acetylaminofluorene; Aminobiphenyl Compounds; Animals; Autoradiography; Carcinogens; Cells, Cultured; Diethylnitrosamine; DNA; DNA Replication; Hydroxyurea; Liver; Male; Mutagens; Nafenopin; Phenobarbital; Rats; Scintillation Counting | 1996 |
Changes in liver fatty acid-binding protein in rat enzyme-altered foci.
Topics: Animals; Antibody Specificity; Carcinogens; Carrier Proteins; Diethylnitrosamine; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; Female; Hepatectomy; Immune Sera; Liver; Myelin P2 Protein; Nafenopin; Neoplasm Proteins; Nerve Tissue Proteins; Phenobarbital; Polychlorinated Biphenyls; Rats; Rats, Sprague-Dawley | 1998 |
Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens.
Topics: Animals; Anti-Bacterial Agents; Apoptosis; Bleomycin; Carcinogens; Cells, Cultured; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nafenopin; Phenobarbital; Proto-Oncogene Proteins c-bcl-2; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 1998 |
Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha.
Topics: Animals; Apoptosis; DNA; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nafenopin; Oxidation-Reduction; Peroxisome Proliferators; Peroxisomes; Phenobarbital; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tumor Necrosis Factor-alpha | 2000 |
Follistatin overexpression in rodent liver tumors: a possible mechanism to overcome activin growth control.
Topics: Activins; Adenoma; Alternative Splicing; Animals; Blotting, Western; Carcinoma, Hepatocellular; Cell Division; Diethylnitrosamine; Follistatin; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Nafenopin; Phenobarbital; Rats; Reference Values; RNA, Messenger; Transforming Growth Factor alpha; Tumor Cells, Cultured | 2002 |
No increase of apoptosis in regressing mouse liver after withdrawal of growth stimuli or food restriction.
Topics: Animals; Apoptosis; DNA; Female; Food Deprivation; Hepatomegaly; Liver; Male; Mice; Mice, Inbred Strains; Nafenopin; Organ Size; Phenobarbital; Protein Biosynthesis; Species Specificity | 2005 |